Page last updated: 2024-09-03

ak 2123 and B16 Melanoma

ak 2123 has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Diatchkovskaya, RF; Kagiya, TV; Konovalova, NP; Volkova, LM	1

Other Studies

1 other study(ies) available for ak 2123 and B16 Melanoma

Article	Year
Radiosensitizer AK-2123 as modulating agent in the chemotherapy of experimental metastases. Neoplasma, 1995, Volume: 42, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Female; Melanoma, Experimental; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Radiation-Sensitizing Agents; Triazoles	1995

Article

Year

Radiosensitizer AK-2123 as modulating agent in the chemotherapy of experimental metastases.

Neoplasma, 1995, Volume: 42, Issue:3

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Female; Melanoma, Experimental; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Radiation-Sensitizing Agents; Triazoles

1995